Target Name: LOC105378022
NCBI ID: G105378022
Review Report on LOC105378022 Target / Biomarker Content of Review Report on LOC105378022 Target / Biomarker
LOC105378022
Other Name(s): Uncharacterized LOC105378022, transcript variant X1 | LOC105378022 variant X1

A closer look at LOC105378022: A Potential Drug Target and Biomarker

LOC105378022 is a gene expression profile that has garnered significant attention due to its potential involvement in drug development. This gene, located on chromosome 6p21.1, has been identified as an expressed gene in various organisms, including humans. LOC105378022 has also been shown to be involved in various cellular processes, including cell adhesion, migration, and invasion.

Recent studies have suggested that LOC105378022 may be a drug target or biomarker, which could have significant implications for the development of new treatments for various diseases. In this article, we will take a closer look at LOC105378022, exploring its potential as a drug target and biomarker.

Potential Drug Target

LOC105378022 has been shown to play a role in the regulation of cell adhesion and migration, which are critical processes that are involved in the development and progression of many diseases. For instance, LOC105378022 has been shown to be involved in the regulation of tight junction formation, which is a critical process that helps maintain the integrity of the blood-brain barrier.

Recent studies have also suggested that LOC105378022 may be involved in the regulation of cancer cell migration. In fact, several studies have shown that LOC105378022 is highly expressed in various types of cancer, including breast, lung, and colorectal cancer. Additionally, LOC105378022 has been shown to play a role in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

These findings suggest that LOC105378022 may be an attractive drug target for the development of new treatments for various diseases. By targeting LOC105378022, researchers could potentially develop new treatments for diseases such as cancer, neurodegenerative diseases, and developmental disorders.

Biomarker

LOC105378022 has also been suggested as a potential biomarker for several diseases. For instance, LOC105378022 has been shown to be highly expressed in various types of cancer, including breast, lung, and colorectal cancer. Additionally, LOC105378022 has been shown to play a role in the regulation of cancer cell migration, which could be used as a biomarker for cancer.

In addition to its potential role as a cancer biomarker, LOC105378022 has also been shown to be involved in the regulation of cell adhesion and migration, which are important processes that are involved in the development and progression of many diseases.

Conclusion

LOC105378022 is a gene expression profile that has potential as a drug target and biomarker. Its involvement in cell adhesion, migration, and cancer cell migration suggests that it may be an attractive target for the development of new treatments for various diseases.

Future studies will be needed to further investigate the potential of LOC105378022 as a drug target and biomarker. By doing so, researchers hope to develop new treatments for diseases that are currently underserved, such as cancer, neurodegenerative diseases, and developmental disorders.

Protein Name: Uncharacterized LOC105378022, Transcript Variant X1

The "LOC105378022 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105378022 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105378058 | LOC105378066 | LOC105378072 | LOC105378082 | LOC105378085 | LOC105378088 | LOC105378091 | LOC105378099 | LOC105378105 | LOC105378110 | LOC105378120 | LOC105378145 | LOC105378146 | LOC105378150 | LOC105378178 | LOC105378189 | LOC105378204 | LOC105378206 | LOC105378228 | LOC105378305 | LOC105378310 | LOC105378314 | LOC105378316 | LOC105378318 | LOC105378327 | LOC105378334 | LOC105378335 | LOC105378339 | LOC105378340 | LOC105378342 | LOC105378347 | LOC105378409 | LOC105378414 | LOC105378460 | LOC105378477 | LOC105378486 | LOC105378492 | LOC105378502 | LOC105378508 | LOC105378515 | LOC105378517 | LOC105378520 | LOC105378525 | LOC105378526 | LOC105378537 | LOC105378543 | LOC105378559 | LOC105378560 | LOC105378586 | LOC105378589 | LOC105378596 | LOC105378605 | LOC105378606 | LOC105378617 | LOC105378641 | LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118 | LOC105379130 | LOC105379133